Led · Series A · Feb 2021

FUNDtastic is an Indonesian investment platform that offers retail investors access to mutual funds and gold investment options. The company acquired mutual funds and securities portal Invisee last year for $6.5 million, enabling it to sell mutual fund products directly. FUNDtastic plans to expand its product roster to include retail bonds, insurance, and peer-to-peer lending. The company raised a $7.7 million Series A to tap rising retail investing demand. FUNDtastic is targeting younger investors, particularly those aged 18 to 30, amid growing retail participation in Indonesia. The company was founded in 2019 and is based in Jakarta.

Participated · Equity · Nov 2020

Prometheus Biosciences is pioneering a precision-medicine approach to discover, develop and commercialize novel therapeutic and companion diagnostic products for inflammatory bowel disease (IBD). The company is led by President and CEO Mark McKenna and is based in San Diego. Its Prometheus 360 platform combines proprietary bioinformatics discovery methods with a gastrointestinal bioinformatics database to identify novel therapeutic targets and advance therapeutic candidates. Prometheus has entered into collaborations to develop targeted therapies for IBD and is supported by a scientific advisory board of IBD experts. Financially, the company completed a $130M equity financing to support its programs. The financing also included board additions to support the company's growth and development plans.